FDA Enforcement Class I Ongoing

t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technology

Recall: Z-1609-2024 · Reported May 15, 2024

Enforcement

Recall Number
Z-1609-2024
Event ID
94312
Classification
Class I
Status
Ongoing
Product Type
Devices
Firm
Tandem Diabetes Care, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
May 15, 2024
Initiation Date
March 5, 2024
Classification Date
May 6, 2024
Address
11075 Roselle St, N/A, San Diego, CA, 92121-1204, United States

Description

t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technology

Reason

During normal use, the mobile app version 2.7 may crash and be automatically relaunched by the iOS operating system. This cycle intermittently repeats, which leads to excessive Bluetooth communication that may result in pump battery drain and may lead to the pump shutting down sooner than typically expected. Pump shutdown will cause insulin delivery to suspend, which could lead to an under-delivery of insulin and may result in hyperglycemia, including severe hyperglycemia.

Code Info

version 2.7 or later /UDI: 00850006613274

Distribution

US nationwide distribution including Puerto Rico.

Quantity

85,863 applications